MDT Stock Recent News
MDT LATEST HEADLINES
The latest trading day saw Medtronic (MDT) settling at $86.97, representing a -0.54% change from its previous close.
Medtronic's global medical device business has supported annual dividend raises since 1978, and it's well positioned for more growth. AbbVie's lead drug fell off a patent cliff last year, but soaring sales of recently launched treatments make the stock a buy right now.
2024 could easily turn into the year that value stocks come out on top. Though “official” numbers say differently, there's a clear sense of unease as tech-heavy indices soar to all-time highs despite wide-ranging layoffs pointing to troubled economic conditions.
We outline an Income Strategy for creating a self-sufficient portfolio for retirees and income-focused investors with $1 million to generate a life-long income stream. We explain the benefits of generating income through dividends and distributions rather than selling shares for capital gains. We compare the results of backtesting an income strategy with index investing for the past 24 years, starting from the year 2000.
After underperforming the broad market over the past year, shares of Medtronic offer a 3.4% dividend yield. AbbVie shares offer a juicy 3.8% dividend yield even though the payout has grown 287% over the past 10 years.
In the wearable medical devices industry, investors can keep a keen eye on stocks such as ABT, MDT and DXCM.
Artificial intelligence (AI) holds promise for many industries, sparking public imagination about the capabilities it may one day attain. However, we must temper expectations when it comes to AI predictions for the stock market.
The final trades of the day with CNBC's Melissa Lee and the Fast Money traders.
Dividend stocks are about to enjoy a renaissance. Just look what happened with Costco (NASDAQ: COST ) last week – the warehouse giant announced a special $15 cash dividend and shares soared to new all-time highs.
In a recent disclosure, United States Representative for Michigan's 6th congressional district Debbie Dingell has come under scrutiny for her stock purchase in Medtronic (NYSE: MDT), a prominent medical devices company.